Nuances of the psychogastroenterology patient: A predictive model for gastrointestinal quality of life improvement
dc.contributor.author | Riehl, Megan E. | |
dc.contributor.author | Kinnucan, Jami A. | |
dc.contributor.author | Chey, William D. | |
dc.contributor.author | Stidham, Ryan W. | |
dc.date.accessioned | 2019-09-30T15:32:17Z | |
dc.date.available | WITHHELD_13_MONTHS | |
dc.date.available | 2019-09-30T15:32:17Z | |
dc.date.issued | 2019-09 | |
dc.identifier.citation | Riehl, Megan E.; Kinnucan, Jami A.; Chey, William D.; Stidham, Ryan W. (2019). "Nuances of the psychogastroenterology patient: A predictive model for gastrointestinal quality of life improvement." Neurogastroenterology & Motility 31(9): n/a-n/a. | |
dc.identifier.issn | 1350-1925 | |
dc.identifier.issn | 1365-2982 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/151345 | |
dc.description.abstract | BackgroundGastrointestinal conditions are multifactorial in nature, and certain patients can benefit greatly from brain–gut psychotherapies delivered by mental health professionals who specialize in psychogastroenterology. This study aimed to identify features associated with improvements in GI‐specific quality of life scores following behavioral health interventions (BHI). The second aim was to create a psychogastroenterology referral care pathway incorporating identified characteristics for greatest benefit from GI‐specific behavioral therapy.MethodsWe performed a prospective observational study of 101 (63 women; median age, 45 years) gastroenterology patients referred for psychogastroenterology consultation at a single center. Patients attended an average of seven sessions with a single GI psychologist where evidence‐based brain–gut psychotherapies were employed. GI‐specific quality of life (IBS‐QOL) and psychological distress (BSI‐18) were assessed before and after BHI. Patients completed self‐reported questionnaires. We performed a multivariable analysis to determine predictors associated with IBS‐QOL score improvement.Key ResultsA total of 53 (52.5%) patients experienced improvement in IBS‐QOL score. Patients with improved IBS‐QOL scores had significantly higher baseline BSI general domain T‐scores (61.9 vs. 56.9, P = 0.002). Female gender (odds ratio [OR], 3.2), pretreatment BSI somatization T‐score ≥63 (OR, 3.7), and a diagnosis of depression (OR, 4.2) were associated with greater odds of IBS‐QOL score improvement following BHI.Conclusions and InferencesWe identified factors associated with response to GI‐specific BHI to aid in optimizing the utilization of psychogastroenterology services and provide referring providers with information to inform treatment recommendations. Female patients with disorders of gut–brain interaction (DGBIs), high somatization, and depression should be considered a priority for brain–gut psychotherapies.Gastrointestinal conditions are multifactorial in nature, and certain patients can benefit greatly from brain–gut psychotherapies delivered by mental health professionals who specialize in psychogastroenterology. Females with disorders of gut–brain interaction, high somatization, and depression should be considered priority for brain–gut psychotherapies. Behavioral health outcomes were not limited to disease; patients with IBD should be routinely considered for referral. Optimizing utilization of GI‐specific behavioral health specialists for the best outcomes can maximize quality of life and disease experience, but also improve value‐based care. | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | inflammatory bowel disease | |
dc.subject.other | disorders of gut–brain interaction | |
dc.subject.other | cognitive behavioral therapy | |
dc.subject.other | psychogastroenterology | |
dc.subject.other | gut‐directed hypnotherapy | |
dc.title | Nuances of the psychogastroenterology patient: A predictive model for gastrointestinal quality of life improvement | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/151345/1/nmo13663.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/151345/2/nmo13663_am.pdf | |
dc.identifier.doi | 10.1111/nmo.13663 | |
dc.identifier.source | Neurogastroenterology & Motility | |
dc.identifier.citedreference | Palsson OS. Standardized hypnosis treatment for irritable bowel syndrome: the North Carolina protocol. Int J Clin Exp Hypn. 2006; 54: 51 ‐ 64. | |
dc.identifier.citedreference | Addolorato G, Mirijello A, D’Angelo C, et al. State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting. Int J Clin Pract. 2008; 62: 1063 ‐ 1069. | |
dc.identifier.citedreference | Gracie DJ, Guthrie EA, Hamlin PJ, Ford AC. Bi‐directionality of brain‐gut interactions in patients with inflammatory bowel disease. Gastroenterology. 2018; 154 ( 6 ): 1635 – 1646.e3. | |
dc.identifier.citedreference | Ballou S, Keefer L. Psychological interventions for irritable bowel syndrome and inflammatory bowel diseases. Clin Transl Gastroenterol. 2017; 8 ( 1 ): e214. | |
dc.identifier.citedreference | Kinsinger SW. Cognitive‐behavioral therapy for patients with irritable bowel syndrome: current insights. Psychol Res Behav Manag. 2017; 10: 231 ‐ 237. | |
dc.identifier.citedreference | Riehl ME, Kinsinger S, Kahrilas PJ, Pandolfino JE, Keefer L. Role of a health psychologist in the management of functional esophageal complaints. Dis Esophagus. 2015; 28: 428 ‐ 436. | |
dc.identifier.citedreference | Taft TH, Ballou S, Bedell A, Lincenberg D. Psychological considerations and interventions in inflammatory bowel disease patient care. Gastroenterol Clin North Am. 2017; 46: 847 ‐ 858. | |
dc.identifier.citedreference | Yadlapati R, Tye M, Keefer L, Kahrilas PJ, Pandolfino JE. Psychosocial distress and quality of life impairment are associated with symptom severity in PPI Non‐responders with normal impedance‐pH profiles. Am J Gastroenterol. 2018; 113: 31 ‐ 38. | |
dc.identifier.citedreference | Drossman DA, Patrick DL, Whitehead WE, et al. Further validation of the IBS‐QOL: a disease‐specific quality‐of‐life questionnaire. Am J Gastroenterol. 2000; 95: 999 ‐ 1007. | |
dc.identifier.citedreference | Drossman D, Morris CB, Hu Y, et al. Characterization of health related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment. Am J Gastroenterol. 2007; 102: 1442 ‐ 1453. | |
dc.identifier.citedreference | Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med. 1983; 13: 595 ‐ 605. | |
dc.identifier.citedreference | DeRogatis H. A different reflection. Nurs Outlook. 1993; 41: 235 ‐ 237. | |
dc.identifier.citedreference | Gracie DJ, Irvine AJ, Sood R, Mikocka‐Walus A, Hamlin PJ, Ford AC. Effect of psychological therapy on disease activity, psychological comorbidity, and quality of life in inflammatory bowel disease: a systematic review and meta‐analysis. Lancet Gastroenterol Hepatol. 2017; 2: 189 ‐ 199. | |
dc.identifier.citedreference | Peters SL, Muir JG, Gibson PR. Review article: gut‐directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease. Aliment Pharmacol Ther. 2015; 41: 1104 ‐ 1115. | |
dc.identifier.citedreference | Palsson OS. Hypnosis treatment of gastrointestinal disorders: a comprehensive review of the empirical evidence. Am J Clin Hypn. 2015; 58: 134 ‐ 158. | |
dc.identifier.citedreference | Laird KT, Tanner‐Smith EE, Russell AC, Hollon SD, Walker LS. Comparative efficacy of psychological therapies for improving mental health and daily functioning in irritable bowel syndrome: a systematic review and meta‐analysis. Clin Psychol Rev. 2017; 51: 142 ‐ 152. | |
dc.identifier.citedreference | Keefer L, Taft TH, Kiebles JL, Martinovich Z, Barrett TA, Palsson OS. Gut‐directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis. Aliment Pharmacol Ther. 2013; 38: 761 ‐ 771. | |
dc.identifier.citedreference | Riehl ME, Keefer L. Hypnotherapy for Esophageal Disorders. Am J Clin Hypn. 2015; 58: 22 ‐ 33. | |
dc.identifier.citedreference | Kiebles JL, Kwiatek MA, Pandolfino JE, Kahrilas PJ, Keefer L. Do patients with globus sensation respond to hypnotically assisted relaxation therapy? A case series report. Dis Esophagus. 2010; 23: 545 ‐ 553. | |
dc.identifier.citedreference | Palsson OS, Whitehead WE. Psychological treatments in functional gastrointestinal disorders: a primer for the gastroenterologist. Clin Gastroenterol Hepatol. 2013; 11 ( 3 ): 208 – 216. | |
dc.identifier.citedreference | Gracie DJ, Hamlin PJ, Ford AC. Longitudinal impact of IBS‐type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel disease. Am J Gastroenterol. 2018; 113: 702 ‐ 712. | |
dc.identifier.citedreference | Allegretti JR, Borges L, Lucci M, et al. Risk factors for rehospitalization within 90 days in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015; 21: 2583 ‐ 2589. | |
dc.identifier.citedreference | Ananthakrishnan AN, Gainer VS, Perez RG, et al. Psychiatric co‐morbidity is associated with increased risk of surgery in Crohn’s disease. Aliment Pharmacol Ther. 2013; 37: 445 ‐ 454. | |
dc.identifier.citedreference | Gonsalkorale WM, Houghton LA, Whorwell PJ. Hypnotherapy in irritable bowel syndrome: a large‐scale audit of a clinical service with examination of factors influencing responsiveness. Am J Gastroenterol. 2002; 97: 954 ‐ 961. | |
dc.identifier.citedreference | Palsson OS, Turner MJ, Johnson DA, et al. Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms. Dig Dis Sci. 2002; 47: 2605 ‐ 2614. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.